300 results on '"Demirkaya, Erkan"'
Search Results
2. A young woman with fever and polyserositis caused by familial Mediterranean fever
3. Relationship of Fatigue, Pain Interference, and Physical Disability in Children Newly Diagnosed With Juvenile Idiopathic Arthritis
4. A case report of a severe neonatal systemic vasculitis on the first day of life
5. A decade of progress in juvenile idiopathic arthritis treatments and outcomes in Canada: results from ReACCh-Out and the CAPRI registry
6. Nanoparticles and cytokine response
7. The 2022 EULAR/ACR Points to Consider at the Early Stages of Diagnosis and Management of Suspected Haemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome (HLH/MAS)
8. P24-038-23 The Role and Importance of Three Basic Mechanisms in Being Healthier: Inflammation, Oxidative Stress and Endothelial Dysfunction
9. Cardiovascular disease risk assessment in patients with familial Mediterranean fever related renal amyloidosis
10. The Effect of Corrected Inflammation, Oxidative Stress and Endothelial Dysfunction on Fmd Levels in Patients with Selected Chronic Diseases: A Quasi-Experimental Study
11. The 2022 EULAR/ACR points to consider at the early stages of diagnosis and management of suspected haemophagocytic lymphohistiocytosis/macrophage activation syndrome (HLH/MAS)
12. Biallelic hypomorphic mutations in a linear deubiquitinase define otulipenia, an early-onset autoinflammatory disease
13. An international delphi survey for the definition of the variables for the development of new classification criteria for periodic fever aphtous stomatitis pharingitis cervical adenitis (PFAPA)
14. Mycoplasma pneumoniae Infections and Primary Immune Deficiencies
15. Anti-Inflammatory, Antioxidant, and Anti-Atherosclerotic Effects of Natural Supplements on Patients with FMF-Related AA Amyloidosis: A Non-Randomized 24-Week Open-Label Interventional Study
16. Number of Episodes Can Be Used as a Disease Activity Measure in Familial Mediterranean Fever
17. The 2021 EULAR/American College of Rheumatology points to consider for diagnosis, management and monitoring of the interleukin-1 mediated autoinflammatory diseases: cryopyrin-associated periodic syndromes, tumour necrosis factor receptor-associated periodic syndrome, mevalonate kinase deficiency, and deficiency of the interleukin-1 receptor antagonist
18. Brief Report: Deficiency of Complement 1r Subcomponent in Early‐Onset Systemic Lupus Erythematosus: The Role of Disease‐Modifying Alleles in a Monogenic Disease
19. The 2021 EULAR/American College of Rheumatology Points to Consider for Diagnosis, Management and Monitoring of the Interleukin‐1 Mediated Autoinflammatory Diseases: Cryopyrin‐Associated Periodic Syndromes, Tumour Necrosis Factor Receptor‐Associated Periodic Syndrome, Mevalonate Kinase Deficiency, and Deficiency of the Interleukin‐1 Receptor Antagonist
20. Number of Episodes Can Be Used as a Disease Activity Measure in Familial Mediterranean Fever
21. Assessment of Surrogate Markers for Cardiovascular Disease in Familial Mediterranean Fever-Related Amyloidosis Patients Homozygous for M694V Mutation in MEFV Gene
22. The 2021 European Alliance of Associations for Rheumatology/American College of Rheumatology Points to Consider for Diagnosis and Management of Autoinflammatory Type I Interferonopathies: CANDLE / PRAAS , SAVI , and AGS
23. The 2021 EULAR and ACR points to consider for diagnosis and management of autoinflammatory type I interferonopathies: CANDLE/PRAAS, SAVI and AGS
24. The relation between delivery type and cord blood levels of chitotriosidase and Troponin T
25. Paediatric Behçet’s Disease: A Comprehensive Review with an Emphasis on Monogenic Mimics
26. Celiac Disease in Juvenile Idiopathic Arthritis and Other Pediatric Rheumatic Disorders
27. Conventional and novel therapeutic options in children with familial Mediterranean fever: A rare autoinflammatory disease
28. A Meta-Analysis to Estimate the Placebo Effect in Randomized Controlled Trials in Juvenile Idiopathic Arthritis
29. 2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Collaborative Initiative
30. 95 Baseline body-mass-index and risk for obesity in children with rheumatic disease starting high-dose prednisone therapy
31. Evaluation of E148Q and Concomitant AA Amyloidosis in Patients with Familial Mediterranean Fever
32. Next Generation Sequencing Based Multiplex Long-Range PCR for Routine Genotyping of Autoinflammatory Disorders
33. Additional file 1 of A case report of a severe neonatal systemic vasculitis on the first day of life
34. Endothelial function in patients with familial Mediterranean fever-related amyloidosis and association with cardiovascular events
35. Clinical Features, Treatment, and Outcome of Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A Multinational, Multicenter Study of 362 Patients
36. Renal Infarcts—A Perplexing Case in the Middle of the COVID-19 Pandemic
37. Infections and Primary Immune Deficiencies.
38. Conventional and novel therapeutic options in children with familial Mediterranean fever: A rare autoinflammatory disease.
39. A pilot study for genome wide association study (GWAS) in patients with juvenile idiopathic arthritis (JIA) and their parents
40. A validation of diagnostic score for molecular analysis of hereditary autoinflammatory syndromes with periodic fever in Turkish children
41. Influence of Reduced Folate Carrier and Aminoimidazole Carboxamide Ribonucleotide Transformylase gene polymorphisms on the efficacy of methotrexate in juvenile idiopathic arthritis
42. Behçet disease: evaluation of clinical manifestations in Turkish children
43. Clinical and demographic characteristics of children with familial mediterranean fever in Central Anatolia
44. Sensitivity and specificity of current diagnostic guidelines in children with macrophage activation syndrome complicating systemic juvenile idiopathic arthritis
45. Effect of ANA positivity on clinical picture of the JIA: should ANA positive JIA be classified as a different group?
46. Recent advances in the management of children with familial Mediterranean fever
47. The 2021 European Alliance of Associations for Rheumatology/American College of Rheumatology Points to Consider for Diagnosis and Management of Autoinflammatory Type I Interferonopathies: CANDLE/PRAAS, SAVI, and AGS.
48. Evaluation of the current disease severity scores in paediatric FMF: is it necessary to develop a new one?
49. Therapeutic approaches in the treatment of juvenile dermatomyositis in patients with recent-onset disease and in those experiencing disease flare: An international multicenter PRINTO study
50. New Horizons in the Genetic Etiology of Systemic Lupus Erythematosus and Lupus-Like Disease: Monogenic Lupus and Beyond
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.